BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29417235)

  • 1. The impact of anaemia, transfusion dependency, comorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes.
    Castelli R; Schiavon R; Deliliers GL
    Med Oncol; 2018 Feb; 35(3):33. PubMed ID: 29417235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes.
    Balleari E; Salvetti C; Del Corso L; Filiberti R; Bacigalupo A; Bellodi A; Beltrami G; Bergamaschi M; Berisso G; Calzamiglia T; Carella AM; Cavalleri M; Da Col A; Favorini S; Forni GL; Goretti R; Miglino M; Mitscheuning L; Molinari E; Racchi O; Scudeletti M; Tassara R; Gobbi M; Lemoli R; Clavio M
    Leuk Res; 2015 Aug; 39(8):846-52. PubMed ID: 26145790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of age and comorbidity in myelodysplastic syndromes.
    Stauder R; Nösslinger T; Pfeilstöcker M; Sperr WR; Wimazal F; Krieger O; Valent P
    J Natl Compr Canc Netw; 2008 Oct; 6(9):927-34. PubMed ID: 18926101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome.
    Della Porta MG; Malcovati L; Strupp C; Ambaglio I; Kuendgen A; Zipperer E; Travaglino E; Invernizzi R; Pascutto C; Lazzarino M; Germing U; Cazzola M
    Haematologica; 2011 Mar; 96(3):441-9. PubMed ID: 21134982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clustering of comorbidities is related to age and sex and impacts clinical outcome in myelodysplastic syndromes.
    Bammer C; Sperr WR; Kemmler G; Wimazal F; Nösslinger T; Schönmetzler A; Krieger O; Pfeilstöcker M; Valent P; Stauder R
    J Geriatr Oncol; 2014 Jul; 5(3):299-306. PubMed ID: 24636334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients.
    Breccia M; Federico V; Latagliata R; Mercanti C; D'Elia GM; Cannella L; Loglisci G; Salaroli A; Santopietro M; Alimena G
    Leuk Res; 2011 Feb; 35(2):159-62. PubMed ID: 20594593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients.
    Stauder R
    Ann Hematol; 2012 Sep; 91(9):1333-43. PubMed ID: 22547053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of older adults with myelodysplastic syndromes (MDS).
    Luskin MR; Abel GA
    J Geriatr Oncol; 2018 Jul; 9(4):302-307. PubMed ID: 29290596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
    Waszczuk-Gajda A; Mądry K; Machowicz R; Drozd-Sokołowska J; Stella-Hołowiecka B; Mital A; Obara A; Szmigielska-Kapłon A; Sikorska A; Subocz E; Jędrzejczak WW; Dwilewicz-Trojaczek J
    Adv Clin Exp Med; 2016; 25(4):633-41. PubMed ID: 27629836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.
    Gattermann N; Kündgen A; Kellermann L; Zeffel M; Paessens B; Germing U
    Eur J Haematol; 2013 Dec; 91(6):473-82. PubMed ID: 24102637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic classification and risk assessment in myelodysplastic syndromes.
    Cazzola M; Malcovati L
    Hematol Oncol Clin North Am; 2010 Apr; 24(2):459-68. PubMed ID: 20359637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome.
    Falantes JF; Márquez-Malaver FJ; Knight T; Calderón-Cabrera C; Martino ML; González J; Montero I; Espigado I; Pérez-Simón JA
    Leuk Lymphoma; 2017 Aug; 58(8):1893-1902. PubMed ID: 27951729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes.
    Wang R; Gross CP; Halene S; Ma X
    Leuk Res; 2009 Dec; 33(12):1594-8. PubMed ID: 19324411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany.
    Gattermann N; Hofmann WK; Meessen A; Schmitz S; Tsamaloukas A; Vollmer T; Wedding U; Plesnila-Frank C; Schramm W; Berger K
    Onkologie; 2008 Sep; 31(8-9):477-84. PubMed ID: 18787357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
    Raptis A; Duh MS; Wang ST; Dial E; Fanourgiakis I; Fortner B; Paley C; Mody-Patel N; Corral M; Scott J
    Transfusion; 2010 Jan; 50(1):190-9. PubMed ID: 19719471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes.
    Ryblom H; Hast R; Hellström-Lindberg E; Winterling J; Johansson E
    Eur J Oncol Nurs; 2015 Apr; 19(2):99-106. PubMed ID: 25488465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need.
    Goldberg SL; Chen E; Sasane M; Paley C; Guo A; Laouri M
    Transfusion; 2012 Oct; 52(10):2131-8. PubMed ID: 22486790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification and prognostic evaluation of myelodysplastic syndromes.
    Cazzola M; Della Porta MG; Travaglino E; Malcovati L
    Semin Oncol; 2011 Oct; 38(5):627-34. PubMed ID: 21943669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A monocentric study on the management of patients with myelodysplastic syndromes in Morocco].
    Maaroufi HE; Ababou M; Hammani A; Ahchouch S; Jennane S; Mahtat M; Mikdmae M; Messaoudi N; Doghmi K
    Pan Afr Med J; 2020; 37():300. PubMed ID: 33654519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.